T2 Biosystems, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
T2 Biosystems, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • T2 Biosystems, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.1M, a 34.4% increase year-over-year.
  • T2 Biosystems, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43M, a 13.8% increase year-over-year.
  • T2 Biosystems, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$50.1M, a 19.2% increase from 2022.
  • T2 Biosystems, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62M, a 25.9% decline from 2021.
  • T2 Biosystems, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$49.2M, a 5.22% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$43M -$10.1M +$5.31M +34.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$48.3M -$8.96M -$2.62M -41.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$45.6M -$13.5M +$4.43M +24.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$50.1M -$10.3M -$241K -2.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$49.8M -$15.4M +$1.95M +11.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$51.8M -$6.35M +$11.7M +64.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$63.5M -$18M -$1.47M -8.91% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$62M -$10.1M +$2.05M +16.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$64M -$17.4M -$3.41M -24.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$60.6M -$18M -$5.56M -44.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-15
Q1 2022 -$55.1M -$16.5M -$5.84M -54.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-15
Q4 2021 -$49.2M -$12.1M -$2.24M -22.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$47M -$14M -$2.71M -24.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$44.3M -$12.5M -$1.79M -16.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$42.5M -$10.7M +$4.29M +28.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$46.8M -$9.91M +$4.13M +29.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$50.9M -$11.3M +$2.92M +20.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$53.8M -$10.7M +$4.96M +31.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$58.8M -$14.9M +$198K +1.31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$59M -$14M +$1.11M +7.31% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$60.1M -$14.2M -$3.4M -31.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$56.7M -$15.6M -$3.32M -27% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$53.4M -$15.1M -$2.23M -17.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$51.2M -$15.1M +$3.04M +16.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$54.2M -$10.8M +$3.31M +23.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$57.5M -$12.3M +$3.13M +20.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$60.6M -$12.9M +$1.79M +12.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$62.4M -$18.2M -$3.64M -25% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$58.8M -$14.1M -$1.29M -10.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$57.5M -$15.5M -$1.41M -10% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$56.1M -$14.7M -$1.28M -9.51% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$54.8M -$14.5M -$2.52M -20.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$52.3M -$12.8M -$1.14M -9.78% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-19
Q2 2016 -$51.1M -$14M -$3.05M -27.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-19
Q1 2016 -$48.1M -$13.4M -$2.81M -26.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-19
Q4 2015 -$45.3M -$12M -$2.96M -32.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$42.3M -$11.6M -$3.55M -43.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$38.8M -$11M -$3.69M -50.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$35.1M -$10.6M -$3.7M -53.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$31.4M -$9.08M -$2.7M -42.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$28.7M -$8.09M -$3.45M -74.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$25.2M -$7.3M -$2.29M -45.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$23M -$6.92M -$2.34M -51.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$20.6M -$6.37M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$4.64M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-04
Q2 2013 -$5.01M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-04
Q1 2013 -$4.58M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.